Evidence map›Paper›PMID 31519770›Full record

ArticleBioscience reports2019

TRPM8 facilitates proliferation and immune evasion of esophageal cancer cells.

Xinyan Lan, Jun Zhao, Chunjing Song, Qiuxiang Yuan, Xiaojun Liu

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. A novel strategy for treating cancer: understanding the role of CaExploration of targeted anti-tumor therapy · 2021
    Review
  19. TRP Channels in Digestive Tract Cancers.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xinyan LanDepartment of Thoracic Surgery, Qingdao Chengyang District People's Hospital, NO. 600 Changcheng Road, Chengyang District, Qingdao 266109, China.
Jun ZhaoDepartment of Thoracic Surgery, Qingdao Chengyang District People's Hospital, NO. 600 Changcheng Road, Chengyang District, Qingdao 266109, China.
Chunjing SongDepartment of Urinary Surgery, Qingdao Chengyang District People's Hospital, NO. 600 Changcheng Road, Chengyang District, Qingdao 266109, China.
Qiuxiang YuanDepartment of Gastroenterology, Qingdao Chengyang District People's Hospital, NO. 600 Changcheng Road, Chengyang District, Qingdao 266109, China.
Xiaojun LiuDepartment of Thoracic Surgery, Qingdao Chengyang District People's Hospital, NO. 600 Changcheng Road, Chengyang District, Qingdao 266109, China.
Qingdao University · CNPeople's Liberation Army 401 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal cancer is seen with increasing incidence, but the underlying mechanism of esophageal cancer is still unknown. Transient receptor potential melastatin (TRPM) is non-selective cation channels. It has been verified that TRPM channels play crucial roles in development and progression of multiple tumors. Increasing studies have shown that TRPM8, a member of TRPM channels, promotes growth of tumors. However, it is still unclear whether TRPM8 has biological effect on esophageal cancer. In the current work, we found that TRPM8 was overexpressed in esophageal cancer samples and cell lines. Further investigation revealed that TRPM8 promoted proliferation of esophageal cancer cells. Next, the co-incubation assay including EC109 cells and CD8+ T cells revealed that TRPM8 overexpression and TRPM8 agonist reduced the cytotoxic effect of CD8+ T cell on esophageal cancer cells. Finally, we explored the mechanism and found that calcineurin-nuclear factor of activated T cells 3 (NFATc3) pathway contributed to the expression of programmed death ligand 1 (PD-L1) induced by TRPM8 overexpression and TRPM8 agonist, which might lead to immune evasion of esophageal cancer cells. These findings uncovered the crucial role of TRPM8 in the pathogenesis of esophageal cancer.

Indexed as

Gene Expression Regulation, NeoplasticA549 CellsB7-H1 AntigenCD8-Positive T-LymphocytesCell LineCell Line, TumorCell ProliferationCell SurvivalEsophageal NeoplasmsHep G2 CellsHumansImmune EvasionNFATC Transcription FactorsRNA InterferenceTRPM Cation ChannelsB7-H1 AntigenNFATC Transcription Factorstranscription factor NF-AT c3TRPM8 protein, humanTRPM Cation ChannelsEsophageal cancerImmune evasionProliferationTRPM8

Identifiers

PMID31519770
PMCPMC6822499
OpenAlexW2972404398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.